|Daily Range||$19.31 - $20.10|
|52-Week Range||$12.07 - $42.34|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||152,493|
|Current FY EPS||-$1.59|
ONCOMED PHARMACEUTICALS INC (OMED) Description
ONCOMED PHARMACEUTICALS INC Website: http://www.oncomed.com/
News & Commentary
Three biotechs climb after a competitor's trial success boosts hope across the HER-2 breast cancer treatment market
OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial Of Tarextumab (Anti-Notch 2/3, OMP-59R5) For Pancreatic Cancer
OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog
OncoMed shares reverse course from Friday's swoon despite the release of mixed news from the company.
Five clinical updates that made waves in the biotech sector this week, as well as the surprising buyout that still has Wall Street abuzz.